Fatal delays in administering life-saving adrenaline autoinjector (EpiPen) for food anaphylaxis, a severe and rapid allergic reaction, is highlighted in research being presented at the Royal College of Emergency Medicine Conference today [28 April]. Researchers are urging for updated guidelines on the use of adrenaline treatment such as EpiPens and the hospital management of severe food anaphylaxis.
At least two school-aged children die each month from knife injuries in England, with most fatalities resulting from a single stab wound, according to the first national analysis of its kind. The University of Bristol-led research offers critical insights that could help inform future prevention strategies.
Extending vaccination opportunities, involving community members alongside healthcare professionals in communicating about vaccines, and providing financial incentives are among the most effective ways to increase vaccine uptake, an analysis of international trial evidence led by the University of Bristol has found. The research, funded by the National Institute for Health and Care Research (NIHR), is published in The BMJ today [15 April].
Researchers have identified and described a previously unknown recessive neurodevelopmental disorder (NDD) that appears to be the most prevalent ever discovered. The study, involving University of Bristol researchers and published in Nature Genetics today [30 March], provides long-awaited answers for many families and may inform future drug development.
The NHS is this month celebrating 40 years of what went on to become the NHS Blood and Transplant (NHSBT) eye bank, with a special appeal from the bank’s longest serving staff member, who is encouraging more people to consider cornea donation as he awaits a fourth cornea transplant himself.
The disposable vapes ban in the UK could lead to young adults switching to alternative products, including cigarettes, new research led by the University of Bristol has found.
Professor Timothy Draycott MD, BSc, MBBS, FRCOG passed away in November 2025. His colleagues offer a remembrance.
The University of Bristol is one of nine UK universities included in a new £50 million 'Inequalities Challenge Consortium' launched by the National Institute for Health and Care Research (NIHR) to support research into addressing inequalities in cardiovascular disease (CVD) which accounts for 26% of all deaths in the UK.
Weight-loss (GLP-1 mimicking) drugs may help prevent further tissue damage following a heart attack, significantly reducing the risk of further life-threatening complications that affect up to half of all patients, according to a new study led by the University of Bristol and University College London (UCL).
A new global analysis of two antenatal treatments that reduce the risk of cerebral palsy and respiratory complications in premature babies reveals significant international variation in implementation. The University of Bristol-led study, published in the International Journal of Obstetrics & Gynaecology today [25 February], examined neonatal data from over 300,000 premature births across ten countries.
A new study has modelled how genes can influence a child’s body mass index (BMI) over time and how they may contribute to the risk of developing diseases, such as heart disease or type 2 diabetes, later in life.
Booster vaccines reduced the risk of COVID 19–related hospitalisation and death, according to a new study of over 3 million adults who had the autumn 2022 vaccine in England. The research led by the universities of Bristol and Oxford, provides further evidence of the effectiveness of booster vaccination against COVID-19.
High body mass index (BMI) could cause a higher risk of vascular-related dementia (a combination of vascular and unspecified dementia), according to new research from the University of Bristol and University Hospital of Copenhagen (Rigshospitalet and Herlev-Gentofte Hospital). The researchers found that the effect of high BMI on dementia mainly works through high blood pressure.
Can sleep affect the progression of Alzheimer’s disease? That’s what a study led by the University of Bristol will explore, thanks to a £4.3 million grant by the Medical Research Council (MRC).
Helping women to keep their blood pressure at normal levels could reduce their risk of experiencing pregnancy complications, according to a new study led by researchers at the University of Bristol. The research is published in BMC Medicine today [14 January].
The prospect of long-lasting drug-free remission for children and adults living with inflammatory arthritis is a step closer to becoming a reality, thanks to a new collaboration between world-leading researchers, including the University of Bristol.
Changing the consumption-driven nature of our food systems would significantly benefit public health and the climate, say the authors of a major scientific review linking environmental harms with obesity.
A pre-school diet and physical activity programme does not improve children’s calorie intake or overall physical activity levels in nursery settings, a new University of Bristol-led study has found. The research published in The Lancet Regional Health - Europe today [18 December] highlights the need for policy-led rather than intervention-led approaches to improving young children’s health.
The week after the autumn clock change is associated with a reduction in demand for NHS services for sleep disorders, cardiovascular disease, anxiety, depression, and psychiatric conditions in England, research led by the University of Bristol has found. The study is published in the Christmas issue of The BMJ today [17 December].
Professor Andrew 'Andy' Whitelaw, Chair in Neonatology at the University of Bristol and consultant neonatologist at Southmead neonatal intensive care unit, died on 9 November 2025 after a short illness. His colleagues in Bristol Medical School and North Bristol NHS Trust offer a tribute.
